Figure 1
Figure 1. SlanDCs are mobilized by G-CSF and display an unaltered phenotype. Peripheral blood samples were collected from the same donors before and after G-CSF treatment. (A) Absolute cell counts of slanDCs (M-DC8+), CD1c+ DCs (lin−, HLA-DR+, CD11c+), and pDCs (lin−, HLA-DR+, CD11c−) were determined as described in “Materials and methods” (n = 13). Individual values and the median are shown. P values were determined using paired t tests. (B) The phenotypic analysis of slanDCs before and after G-CSF administration is compared. Results of one representative donor are shown (n = 5). Staining of PBMCs and gating were performed as described.12,13

SlanDCs are mobilized by G-CSF and display an unaltered phenotype. Peripheral blood samples were collected from the same donors before and after G-CSF treatment. (A) Absolute cell counts of slanDCs (M-DC8+), CD1c+ DCs (lin, HLA-DR+, CD11c+), and pDCs (lin, HLA-DR+, CD11c) were determined as described in “Materials and methods” (n = 13). Individual values and the median are shown. P values were determined using paired t tests. (B) The phenotypic analysis of slanDCs before and after G-CSF administration is compared. Results of one representative donor are shown (n = 5). Staining of PBMCs and gating were performed as described.12,13 

Close Modal

or Create an Account

Close Modal
Close Modal